Edition:
United States

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

980.20DKK
6:12am EST
Change (% chg)

kr.-4.80 (-0.49%)
Prev Close
kr.985.00
Open
kr.985.40
Day's High
kr.995.00
Day's Low
kr.966.80
Volume
89,048
Avg. Vol
223,673
52-wk High
kr.1,335.00
52-wk Low
kr.786.20

Chart for

About

Genmab A/S is a Denmark-based biotechnology company. It is engaged in the development of differentiated human antibody therapeutics for the treatment of cancer, as well as other medical conditions, such as relapsing remitting multiple sclerosis. Its product pipeline includes a number of research and development projects in... (more)

Overall

Beta: 1.29
Market Cap(Mil.): kr.60,489.01
Shares Outstanding(Mil.): 61.50
Dividend: --
Yield (%): --

Financials

  GEN.CO Industry Sector
P/E (TTM): 42.90 95.96 30.88
EPS (TTM): 22.93 -- --
ROI: 22.69 0.60 13.80
ROE: 22.70 -2.18 15.29

Earnings vs. Estimates